PAREXEL Expands Clinical Trial Supply, Logistics Services
Parexel announced the opening of its new European Coordination Hub and Distribution Center in Berlin-Sch?nefeld.
Parexel announced the opening of its new European Coordination Hub and Distribution Center in Berlin-Schönefeld, Germany. Its capabilities include synchronized coordination of clinical trial supplies, ancillary supplies and central laboratory services and features more than 65,000 cubic meters of storage space. It offers lab-kit assembly and provides storage and distribution of ancillary materials.
The new European Coordination Hub and Distribution Center will be licensed to store Investigational Medicinal Products (IMPs) and Non-Investigational Medicinal Products (N-IMPs). It will also offer secondary packaging, re-labeling, and compliance with Good Distribution Practice (GDP) of medical devices and ambient, refrigerated and frozen medicinal products, including controlled substances. On-site Qualified Person (QP), Quality Control (QC) and production personnel will manage regulatory-compliance requirements. They will also streamline product import, receipt, storage, packaging and labeling, release, shipment, return and destruction timelines.
PAREXEL also is opening new full-service clinical trial supply depots in Buenos Aires, Argentina, and São Paulo, Brazil. The facilities are part of PAREXEL’s growing global system of more than 50 owned or in-network depots and three regional distribution centers.
Read the full release here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
